MÖLNDAL, Sweden, Sept. 1, 2025 /PRNewswire/ —
First quarter 2025/26 (May – July)
- Net sales amounted to SEK 23.8 (18.5) million.
- Operating loss totalled SEK 12.4 (12.0) million.
- Profit/loss after tax amounted to SEK -10.0 (-9.4) million.
- Earnings per share amounted to SEK -0.47 (-0.49).
- Cash flow totalled SEK -12.4 (29.3) million.
Significant events in the first quarter
- In May the company appointed Martin Hillsten as the new CEO. He succeeds interim CEO Scott Flora.
- Also in May, the company entered into a commercial distribution agreement with the niche company Labormed d.o.o., which distributes medical equipment for orthopaedic treatments in Slovenia.
- In the same month, the company signed an agreement with Bionics Group Ukraine LLC., a specialist in the distribution and integration of medical equipment to hospitals and private clinics in Ukraine. The agreement covers units used in the surgical implantation (S1 and S2 procedures) of the OPRA® Implant System.
- In June, the company announced the appointment of Louise Wåhlin as the new Chief Financial Officer. She will assume her new position on 15 September 2025.
- In July, the independent bid committee of Integrum AB resolved to recommend that the shareholders of Integrum AB accept the public offer made by OsteoCentric Oncology and Bone Anchored Prostheses, LLC.
Significant events after the quarter
- After the end of the quarter the company announced that it will assume the role of Legacy Sponsor, the main sponsor, of the Global Collaborative Congress on Osseointegration (GCCO) held annually in Charlotte, North Carolina, USA. GCCO brings together leading professionals to share knowledge, improve outcomes and foster research collaborations in the field of osseointegration.
- In August, Integrum AB closed its credit facility of SEK 10 million.
CEO’s statement
Positive sales performance in the US following the company’s strategic shift
In the first quarter of the financial year, sales in the US continued to develop positively compared with the same period in the previous year. The US market now accounts for an increasingly dominant …